Výsledky vyhledávání
- 1.HLAVACKOVA, A.; VYDRA, J.; KOVAROVA, H.; CHRASTINOVA, L.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Significant differences of serum metabolism in acute myeloid leukemia WITH IDH2 mutations. [Prezentováno: EHA-SWG scientific meeting on MDS/MPN/AML: commonalities and differences of myeloid neoplasms. Budapest, 2.11.-4.11.2023.].
- 2.CHRASTINOVÁ, L.G; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; CEZNEROVÁ, E.; KOTLÍN, R.; PECHERKOVÁ, P.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; HAVLÍČEK, M.; VÁLKA, J.; HOMOLA , J.; SUTTNAR, J. Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array. Scientific reports. 2023, vol. 13, no. 1, art. no. 12816. ISSN 2045-2322.
- 3.SVOBODA, N.; KOČÍ, K.; SEIDLOVÁ, A.; MANDYS, V.; SUTTNAR, J.; HLAVÁČKOVÁ, A.; ET AL. Oxidative stress as a reliable biomarker of carotid plaque instability: a pilot study. Antioxidants. 2023, vol. 12, no. 2, art. no. 506. ISSN 2076-3921.
- 4.HRUSTINCOVA, A.; TRSOVA, I.; KREJCIK, Z.; KUNDRAT, D.; BELICKOVA, M.; KAISRLIKOVA, M.; VESELA, J.; KLEMA, J.; RYSAVY, P.; SUTTNAR, J.; HLAVACKOVA, A.; JONASOVA, A.; CERMAK, J.; DOSTALOVA MERKEROVA, M. SF3B1 mutations and their impact on cellular bioenergetics in myelodysplastic syndromes. Leukemia research. 2023, vol. 128, no. Supplement, s. 71. ISSN 0145-2126.
- 5.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; KOVAROVA, H.; STIKAROVA, J.; SUTTNAR, J. Targeted metabolomic profiling of AML patients: the effect of conditioning regimens on post-transplantation complications. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 6.CHRASTINOVÁ, L.; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; VÁLKA, J.; HOMOLA J.; SUTTNAR, J. Aberrant glycosylation patterns in myelodysplastic syndrome: a lectin array study. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 7.BOCKOVÁ, M.; ŠPRINGER, T.; CHRASTINOVÁ, L.; KREJČÍK, Z.; SUTTNAR, J.; HOMOLA, J. Advances in plasmonic biosensors and their applications in oncohematology. [Prezentováno: Czech Annual Cancer Research Meeting. Olomouc, 1.12.-2.12.2022.].
- 8.MALY, M.; RIEDEL, T.; STIKAROVA, J.G; SUTTNAR, J.; KOTLIN, R.; HAJSL, M.; TOUSEK, P.; KAUFMANOVA, J.; KUCERKA, O.; WEISEL, J.W.; DYR, J.E. Incorporation of fibrin, platelets, and red blood cells into a coronary thrombus in time and space. Thrombosis and haemostasis. 2022, vol. 122, no. 3, s. 434-444. ISSN 0340-6245.
- 9.SOVOVA, Z.G; PECANKOVA, K.; MAJEK, P.; SUTTNAR, J. Extension of the human fibrinogen database with detailed clinical information: the alpha c‐connector segment. International journal of molecular sciences. 2022, vol. 23, no. 1, art. no. 132. ISSN 1422-0067.
- 10.CEZNEROVÁ, E.; KAUFMANOVÁ, J.; SOVOVÁ, Ž.; ŠTIKAROVÁ, J.; LOUŽIL, J.; KOTLÍN, R.G; SUTTNAR, J. Structural and functional characterization of four novel fibrinogen mutations in FGB causing congenital fibrinogen disorder. International journal of molecular sciences. 2022, vol. 23, no. 2, art. no. 721. ISSN 1422-0067.